from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3178/-

LFCtreatmentdescriptionclass of inhibitor

-0.829

Amikacinug/mL Amikacintranslation

-0.772

Cap5-10ug/mL Capreomycintranslation

-0.316

Rox10-50 ug/mL Roxithromycintranslation

-0.774

SM2-5 ug/mL Streptomycintranslation

-0.990

Tet5-10 ug/mL Tetracyclinetranslation

0.186

Rif0.2-5ug/mL Rifampicintranscription

-0.511

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.095

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.154

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.175

CPZ10-50 ug/mL Chlorpromazinerespiration

0.314

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.779

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.866

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.021

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.127

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.089

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.550

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.289

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.849

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.631

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.877

KCN5-20 ug/mL Potassium cyaniderespiration

0.395

NaN30.2-2 mM Sodium aziderespiration

0.167

Nigericin50 uM Nigericinrespiration

-0.014

TRC10-150 ug/mL Triclosanrespiration

-0.468

TRZ10-25 ug/mL Thioridazinerespiration

1.297

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.715

menadione6-10 ug/mL Menadionerespiration

0.639

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.112

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

1.079

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.321

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.116

NRP_1Non-replicating persistence stage 1dosRassociated

-0.127

Amp0.2mg/mL AmpicillincellWall

-0.322

Cephalexin20-100 ug/mL CephalexincellWall

-0.114

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.070

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.306

EMB10-20 ug/mL EthambutolcellWall

-0.345

Eta12-40 ug/mL EthionamidecellWall

-0.744

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.005

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.607

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.461

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.874

BZA0.12 mg/mL BenzamidearomaticAmides

0.586

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.772

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.781

H2O24 mM hydrogen peroxideDNAdamaging

-0.124

Levo10 ug/mL LevofloxacinDNAdamaging

0.423

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.915

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.684

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.345

UVUV-irradiationDNAdamaging

3.370

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.330

Antimycin12.5-50 ug/mL Antimycin A?

-0.198

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.958

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.112

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.440

PA8240.2-2 ug/mL PA-824?

-1.085

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.914

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.555

Verapamil50 uM Verapamil?

0.080

mercaptoethanol2 mM 2-Mercaptoethanol?

0.288

methoxatin10-20 ug/mL Methoxatin?